Private-Label Momentum Grows With Mass Retailers’ Low-Price Programs

The private-label sector, already growing as consumers react to a weak economy, received a boost when mass-market retailers Wal-Mart and Target added nonprescription drugs to low-price pharmacy programs

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet